Drug profile · INN
esmolol hydrochloride
ESMOLOL HYDROCHLORIDE
esmolol hydrochloride (ESMOLOL HYDROCHLORIDE) is a beta-2 adrenergic receptor antagonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Drug details — esmolol hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 2
- Programs
- 0
- Data quality
- 0.89
Quick answer
esmolol hydrochloride (ESMOLOL HYDROCHLORIDE) is a beta-2 adrenergic receptor antagonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-2 adrenergic receptor antagonist
Primary target: Beta-1 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is esmolol hydrochloride?
esmolol hydrochloride (ESMOLOL HYDROCHLORIDE) is a beta-2 adrenergic receptor antagonist. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
What is the brand name for esmolol hydrochloride?
ESMOLOL HYDROCHLORIDE is a marketed brand name for esmolol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of esmolol hydrochloride?
esmolol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.